Birdwatch Note Rating
2024-04-16 13:42:29 UTC - HELPFUL
Rated by Participant: AF68D12B74001A04CE1EA441D4445B708328A6BFEDFC3F34019DD0C50A76AD19
Participant Details
Original Note:
This study is about daily ketamine abusers (2–9.7 years; mean use 2.4 g/day). Esketamine has been approved as a treatment for depression in both the United States and Europe. Low dose ketamine schedules have strong antidepressant effects in depressed patients. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972190/
All Note Details